World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
75
Citations
51633
World Ranking
18953
National Ranking
9448

Overview

Neal I. Lindeman is affiliated with Brigham and Women's Hospital in the United States. Their research spans multiple fields of study within medicine, with a particular focus on cancer research, oncology, and genetics, supported by extensive publications in both broad and specialized biomedical disciplines.

Their main fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these broad fields, Lindeman's subfields of specialization cover:

  • Cancer Research
  • Oncology
  • Genetics
  • Pulmonary and Respiratory Medicine
  • Molecular Biology

Their work focuses on several specific topics, notably:

  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Neuroblastoma Research and Treatments
  • Genetic factors in colorectal cancer
  • Genomics and Rare Diseases
  • Lung Cancer Treatments and Mutations
  • Glioma Diagnosis and Treatment

Neal I. Lindeman has authored numerous papers in well-regarded journals. Some recent papers include:

  • Fatty acid synthesis is required for breast cancer brain metastasis, 2021, Nature Cancer
  • Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer, 2020, Clinical Cancer Research
  • A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study, 2021, Neuro-Oncology
  • Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer, 2022, Nature Medicine
  • Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E-Driven Papillary Thyroid Cancer Patients, 2021, Clinical Cancer Research

Frequently publishing venues for Lindeman include:

  • Clinical Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • JCO Precision Oncology
  • Archives of Pathology & Laboratory Medicine

The scientist collaborates regularly with several frequent co-authors, listed here by name and number of collaborations:

  • Bruce E. Johnson (22 articles)
  • Laura E. MacConaill (19 articles)
  • Lynette M. Sholl (18 articles)
  • Ethan Cerami (16 articles)
  • Katherine A. Janeway (15 articles)

Best Publications

  • EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

    J. Guillermo Paez;Pasi A. Jänne;Pasi A. Jänne;Jeffrey C. Lee;Sean Tracy

  • MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

    Jeffrey A. Engelman;Kreshnik Zejnullahu;Tetsuya Mitsudomi;Youngchul Song

  • Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

    Neal I. Lindeman;Philip T. Cagle;Mary Beth Beasley;Dhananjay Arun Chitale

  • Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists

    Marilyn M. Li;Michael Datto;Eric J. Duncavage;Shashikant Kulkarni

  • Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

    Neal I. Lindeman;Philip T. Cagle;Dara L. Aisner;Maria E. Arcila

  • Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review

    Jason D. Merker;Geoffrey R. Oxnard;Carolyn Compton;Maximilian Diehn

  • Characterizing the cancer genome in lung adenocarcinoma

    Barbara A. Weir;Barbara A. Weir;Michele S. Woo;Gad Getz;Sven Perner;Sven Perner

  • Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC

    Alexa B. Turke;Kreshnik Zejnullahu;Yi Long Wu;Youngchul Song

  • LKB1 modulates lung cancer differentiation and metastasis

    Hongbin Ji;Matthew R. Ramsey;D. Neil Hayes;Cheng Fan

  • EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

    Jussi P. Koivunen;Craig Mermel;Kreshnik Zejnullahu;Carly Murphy

  • Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

    R. Coleman Lindsley;Brenton G. Mar;Emanuele Mazzola;Peter V. Grauman

  • Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.

    Scott J. Rodig;Mari Mino-Kenudson;Sanja Dacic;Beow Y. Yeap

  • Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib

    David M. Jackman;Beow Y. Yeap;Lecia V. Sequist;Neal Lindeman

  • A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors

    Takaaki Sasaki;Jussi Koivunen;Atsuko Ogino;Masahiko Yanagita

  • Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine

    Eliezer M Van Allen;Nikhil Wagle;Petar Stojanov;Danielle L Perrin

  • A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry.

    Mari Mino-Kenudson;Lucian R. Chirieac;Kenny Law;Jason L. Hornick

  • Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.

    Elizabeth P. Garcia;Alissa Minkovsky;Yonghui Jia;Matthew D. Ducar

  • Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing

    Roman K. Thomas;Elizabeth Nickerson;Jan F. Simons;Pasi A. Jänne

  • Phase II Clinical Trial of Chemotherapy-Naïve Patients ≥ 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer

    David M. Jackman;Beow Y. Yeap;Neal I. Lindeman;Panos Fidias

  • Differential Effects of Gefitinib and Cetuximab on Non–small-cell Lung Cancers Bearing Epidermal Growth Factor Receptor Mutations

    Toru Mukohara;Jeffrey A. Engelman;Nasser H. Hanna;Beow Y. Yeap

Frequent Co-Authors

Pasi A. Jänne
Pasi A. Jänne Harvard University
Lynette M. Sholl
Lynette M. Sholl Brigham and Women's Hospital
Bruce E. Johnson
Bruce E. Johnson Harvard University
Levi A. Garraway
Levi A. Garraway Roche (United States)
Eliezer M. Van Allen
Eliezer M. Van Allen Harvard University
Azra H. Ligon
Azra H. Ligon Brigham and Women's Hospital
Matthew Meyerson
Matthew Meyerson Harvard University
Judy Garber
Judy Garber Harvard University
David J. Kwiatkowski
David J. Kwiatkowski Brigham and Women's Hospital
Rameen Beroukhim
Rameen Beroukhim Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to diverse online degrees and specialized career tracks. For those aiming to start patient care quickly, consider accelerated lpn programs online. These fast-track pathways allow you to become a Licensed Practical Nurse in less time, combining flexibility with a hands-on medical foundation.

If you’re interested in advanced nursing with a mental health focus, psych np online programs can lead to licensure as a Psychiatric-Mental Health Nurse Practitioner. This specialty is in high demand, offering strong career prospects in clinical and community settings.

For those drawn to the business side of healthcare, a bachelors in healthcare administration provides the management skills needed to lead hospitals, clinics, or public health organizations. For further advancement, pursuing one of the cheapest mha programs online healthcare can prepare you for executive roles, all while keeping tuition costs affordable.

These online healthcare degrees offer flexibility, affordability, and clear pathways—no matter your stage in the field of medicine.

Best Scientists Citing Neal I. Lindeman

Trending Scientists

Recently Published Articles